Suzuki, Tetsuya Hayakawa, Kayoko Ainai, Akira Iwata-Yoshikawa, Naoko Sano, Kaori Nagata, Noriyo Suzuki, Tadaki Wakimoto, Yuji Akiyama, Yutaro Miyazato, Yusuke
...
Published in
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Information on the effectiveness of personal protective equipment (PPE) for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among healthcare workers (HCWs), especially among HCWs with frequent contact with patients with SARS-CoV-2, is limited. We conducted a prospective cohort study on 49 HCWs who worked in close c...
Gupta, Vikash Kumar Alkandari, Buthaina Mohammad Mohammed, Wasif Tobar, Ahmed Mohamed Abdelmohsen, Mohsen Ahmed
Published in
European journal of radiology open
Management of severe coronavirus disease 2019 requires advanced respiratory support modalities including invasive mechanical ventilation (IMV), continuous positive airway pressure (C-PAP), and non-invasive ventilation ((NIV). IMV leads to either subtle forms of lung injury (pulmonary edema, lung cysts) or more severe form of lung injury manifested ...
Rouillard, Smita Liu, Vincent X Corley, Douglas A
Published in
Gastroenterology
Kim, Michael G Stein, Alan A Overby, Philip Kleinman, George Nuoman, Rolla Gulko, Edwin Al-Mufti, Fawaz Pisapia, Jared M Muh, Carrie R
Published in
Pediatric neurology
Kosaka, Makoto Yamazaki, Yoshitaka Maruno, Takashi Sakaguchi, Koji Sawaki, Shoji
Published in
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
The effect of systemic corticosteroids on clinical outcomes in patients with coronavirus disease 2019 (COVID-19) remains controversial. While the use of corticosteroids raises concerns regarding delayed viral clearance, secondary infections, and long-term complications that can lead to increased mortality, corticosteroids have the potential to redu...
Zhong, Wen-Jing Duan, Jia-Xi Liu, Tian Yang, Hui-Hui Guan, Xin-Xin Zhang, Chen-Yu Yang, Jin-Tong Xiong, Jian-Bing Zhou, Yong Guan, Cha-Xiang
...
Published in
International immunopharmacology
NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome and triggering receptor expressed on myeloid cells-1 (TREM-1) are considered critical orchestrators of the inflammatory response in acute lung injury (ALI). However, few assumptions are based on the relationship between them. Here, we investigated the effect of NLRP3 inflammasome activat...
Kouri, Andrew Gupta, Samir Yadollahi, Azadeh Ryan, Clodagh M Gershon, Andrea S To, Teresa Tarlo, Susan M Goldstein, Roger S Chapman, Kenneth R Chow, Chung-Wai
...
Published in
Chest
To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objective meas...
Neumann, Bernhard Schmidbauer, Moritz L Dimitriadis, Konstatinos Otto, Sören Knier, Benjamin Niesen, Wolf-Dirk Hosp, Jonas A Günther, Albrecht Lindemann, Sarah Nagy, Gabor
...
Published in
Journal of the neurological sciences
Wolf, Johannes Kaiser, Thorsten Pehnke, Sarah Nickel, Olaf Lübbert, Christoph Kalbitz, Sven Arnold, Benjamin Ermisch, Jörg Berger, Luisa Schroth, Stefanie
...
Published in
Clinica Chimica Acta; International Journal of Clinical Chemistry
Background Serological severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays differ in the target antigen specificity, e.g. of antibodies directed against the viral spike or the nucleocapsid protein, and in the spectrum of detected immunoglobulins. The aim of the study was to evaluate the performance of two different routinel...
Yan, Bohua Jiang, Zhiwei Yuan, Jing Li, Minghui Zeng, Jieping Tang, Jianyuan Lu, Z Kevin Ding, Hong Xia, Jielai Wang, Qiaoling
...
Published in
Phytomedicine : international journal of phytotherapy and phytopharmacology
Since the declaration of COVID-19 as a global pandemic by the World Health Organization, countries are struggling with a shortage of medical capacities. It would be essential if the risk for preventable comorbidities, such as the common cold, can be reduced or prevented, so that the scarce medical resources and facilities can be focused on COVID-19...
